The Corn Lab

The Corn Lab develops and uses next-generation genome editing and regulation technologies. We work on both fundamental biological discovery and potential therapies for human genetic diseases. Our focus is the mechanisms by which cells repair their DNA, maintain and differentiate hematopoietic stem cells, and dispose of entire organelles. Through technology development, mechanistic cellular biochemistry, and translational projects, we are working to unravel complex cellular phenotypes to further biological understanding and improve human health.

Our work is supported by the Swiss National Science Foundation, the European Research Council, the NCCR RNA & Disease, the Fanconi Anemia Research Fund, the Bill and Melinda Gates Foundation, the NOMIS Foundation, and the Lotte and Adolf Hotz-Sprenger Foundation.

News

September 8, 2023

THE EXPLAINER VIDEO FEATURING OUR HBD PROMOTER RESEARCH IS NOW LIVE!

Check out our new animated video highlighting Mandy’s research on HBD promoter engineering!

 

To learn more, please refer to this article on Elife...

September 7, 2023

Welcome to Iryna!

Iryna Vykhlyantseva completed her master’s degree in Biotechnology in late 2022. She joined the Corn Lab’s supporting the GEML team as a research...

September 7, 2023

Welcome to Xin!

Xin Luo received her Bachelor’s degree from University of Melbourne in 2021. She is currently enrolled in the Biochemistry Master’s program at ETH Zürich....

News Archive

Tweets

Contact Us

Questions and/or comments about Corn Lab and its activities may be addressed to:

JACOB.CORN@BIOL.ETHZ.CH

Share: